CWM
BMY icon

CarsonAllaria Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

CarsonAllaria Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,556
Closed -$72.1K – 106
2025
Q2 		$72.1K Hold
1,556
– – 0.04% 119
2025
Q1 		$95K Hold
1,556
– – 0.06% 104
2024
Q4 		$88.1K Hold
1,556
– – 0.05% 108
2024
Q3 		$80.6K Hold
1,556
– – 0.05% 111
2024
Q2 		$64.7K Sell
1,556
-60
-4% -$2.69K 0.04% 117
2024
Q1 		$87.7K Hold
1,616
– – 0.06% 110
2023
Q4 		$83K Sell
1,616
-453
-22% -$23.8K 0.06% 98
2023
Q3 		$120K Sell
2,069
-556
-21% -$34.1K 0.1% 82
2023
Q2 		$168K Sell
2,625
-29
-1% -$1.95K 0.13% 75
2023
Q1 		$184K Buy
2,654
+17
+0.6% +$1.2K 0.16% 70
2022
Q4 		$190K Sell
2,637
-142
-5% -$10.7K 0.17% 69
2022
Q3 		$198K Buy
2,779
+17
+0.6% +$1.23K 0.18% 65
2022
Q2 		$213K Buy
2,762
+15
+0.5% +$1.14K 0.2% 62
2022
Q1 		$201K Buy
2,747
+19
+0.7% +$1.28K 0.18% 62
2021
Q4 		$170K Buy
+2,728
New +$160K 0.15% 73

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CarsonAllaria Wealth Management's BMY Position: Q3 2025 in Review

CarsonAllaria Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 1,556 shares — an estimated $72.1K sold.

CarsonAllaria Wealth Management first reported a position in BMY in Q4 2021 and held it in 15 quarters. The position peaked at $213K in Q2 2022. 2,276 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • CarsonAllaria Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 1,556 Bristol-Myers Squibb shares in Q3 2025, an estimated $72.1K.
  • CarsonAllaria Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 15 quarters.
  • CarsonAllaria Wealth Management's Bristol-Myers Squibb position peaked at $213K in Q2 2022.
  • 2,276 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.